Shanghai Universal Biotech Co.,Ltd. (SHE:301166)

Market Cap	2.72B +14.2%
Revenue (ttm)	1.07B -8.7%
Net Income	-19.01M
EPS	-0.22
Shares Out	85.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	0.23 (0.71%)
Ex-Dividend Date	May 22, 2025

Volume	1,683,200
Average Volume	1,337,306
Open	32.58
Previous Close	32.61
Day's Range	31.52 - 32.58
52-Week Range	28.48 - 36.42
Beta	1.13
RSI	54.29
Earnings Date	Apr 28, 2026

About SHE:301166

Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as immunology reagents, molecular biology reagents, cell biology reagents and biochemical reagents. It also provides technical services, technology promotion, technology information exchange, scientific and technology training, technology consulting, technology incubation and other services, as well as experimental services and software solutions....

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 698
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301166

Financial Performance

In 2024, SHE:301166's revenue was 1.12 billion, a decrease of -8.82% compared to the previous year's 1.23 billion. Earnings were 10.15 million, a decrease of -74.83%.